NSE filing, NSE: SOTAC. Summary written from the filing by ALFA Finder's alert engine.
Sotac Pharmaceuticals Limited: key numbers
- Share price
- ₹111.65
- Market cap
- ₹123.4 Cr
- Revenue (annual)
- ₹101.2 Cr
- Net profit (annual)
- ₹6.29 Cr
- P/E (TTM)
- 19.6×Sector 45.9×
- Promoter holding
- 72.85%
- FII holding
- 16.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sotac Pharmaceuticals Limited
All →Sotac Pharmaceuticals Annual General Meeting
Sotac's EGM sought shareholder approval to raise authorised share capital from Rs.11.5 crore to Rs.15 crore. The video-conference meeting had one resolution.
Sotac Pharmaceuticals Annual General Meeting
Sotac Pharmaceuticals will hold an Extraordinary General Meeting on October 31, 2026, to seek shareholder approval for an increase in the company's authorised share capital.
Sotac Pharmaceuticals Capital Structure Change
Sotac Pharmaceuticals approved increasing its authorized share capital to Rs. 15 Crore. An Extra-Ordinary General Meeting will be convened to seek shareholder approval for this change.
Sotac Pharmaceuticals Dividend
Sotac Pharmaceuticals Limited has announced a record date of September 23, 2026, for the payment of a final dividend of Rs. 0.20 per share.
Sotac Pharmaceuticals Annual General Meeting
Sotac Pharmaceuticals Limited issued the notice for its 11th Annual General Meeting on September 30, 2026. Ordinary and special business will be transacted.
Sotac Pharmaceuticals Bags ₹0.98 Cr Order
Sotac Pharmaceuticals received a purchase order from Intas Pharmaceuticals Limited for finished pharmaceutical formulations. The order is valued at ₹0.98 Crore.
- Value
- ₹0.98 Cr
- Execution
- September 05, 2026 to November 05, 2026
Other board meeting outcome announcements
All →Teja Engineering Industries Board Meeting Outcome
Teja Engineering Industries informed NSE that its board appointed K. J. Tapiawala & Associates as internal auditor and N R Shah & Co as secretarial auditor for FY 2026-27. Both are routine appointments with no monetary value.
- Execution
- FY 2026-27
SC Agrotech Board Meeting Outcome
SC Agrotech's board approved shifting its corporate office to Sola, Ahmedabad, effective October 31, 2026. The registered office stays unchanged in Delhi.
Abril Paper Tech Board Meeting Outcome
Abril Paper Tech appointed K. J. Tapiawala & Associates as internal auditor for FY 2026-27. The appointment is a routine auditor change with no financial or operational impact.
- Execution
- Financial Year 2026-27
Bridge Securities Board Meeting Outcome
Bridge Securities' board approved moving its registered office within Ahmedabad, effective 31 October 2026. The routine administrative change has no financial impact.
VCU Data Management Board Meeting Outcome
VCU Data Management appointed M/s. Utkarsh Shah & Co. as Secretarial Auditors for five years from FY 2026-27, subject to AGM approval. No monetary amount is disclosed, so this is an auditor appointment intimation.
- Execution
- FY 2026-27 to 2030-31 (five years)
Hardcastle & Waud Manufacturing Company Board Meeting Outcome
The board revoked its earlier Mumbai office shift and approved moving the registered office to Mira Road, Thane. The change awaits shareholder and regulatory approval.